Global Oxytocic Pharmaceuticals Market Insights, Forecast to 2025

Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.
The global Oxytocic Pharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oxytocic Pharmaceuticals market based on company, product type, end user and key regions.

This report studies the global market size of Oxytocic Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oxytocic Pharmaceuticals in these regions.
This research report categorizes the global Oxytocic Pharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Oxytocic Pharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva

Market size by Product
Natural Oxytocin
Synthetic Oxytocin Derivative
Market size by End User
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Oxytocic Pharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oxytocic Pharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oxytocic Pharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oxytocic Pharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oxytocic Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oxytocic Pharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Oxytocic Pharmaceuticals Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by Product
1.4.2 Natural Oxytocin
1.4.3 Synthetic Oxytocin Derivative
1.5 Market by End User
1.5.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by End User
1.5.2 Abortion Induced Incomplete
1.5.3 Inevitable Abortion
1.5.4 Post-partum Haemorrhage
1.5.5 Labour Induction
1.5.6 Labour Arrest
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Oxytocic Pharmaceuticals Market Size
2.1.1 Global Oxytocic Pharmaceuticals Revenue 2014-2025
2.1.2 Global Oxytocic Pharmaceuticals Sales 2014-2025
2.2 Oxytocic Pharmaceuticals Growth Rate by Regions
2.2.1 Global Oxytocic Pharmaceuticals Sales by Regions
2.2.2 Global Oxytocic Pharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Oxytocic Pharmaceuticals Sales by Manufacturers
3.1.1 Oxytocic Pharmaceuticals Sales by Manufacturers
3.1.2 Oxytocic Pharmaceuticals Sales Market Share by Manufacturers
3.1.3 Global Oxytocic Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Oxytocic Pharmaceuticals Revenue by Manufacturers
3.2.1 Oxytocic Pharmaceuticals Revenue by Manufacturers (2014-2019)
3.2.2 Oxytocic Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
3.3 Oxytocic Pharmaceuticals Price by Manufacturers
3.4 Oxytocic Pharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Oxytocic Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oxytocic Pharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Oxytocic Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Oxytocic Pharmaceuticals Sales by Product
4.2 Global Oxytocic Pharmaceuticals Revenue by Product
4.3 Oxytocic Pharmaceuticals Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Oxytocic Pharmaceuticals Breakdown Data by End User

6 North America
6.1 North America Oxytocic Pharmaceuticals by Countries
6.1.1 North America Oxytocic Pharmaceuticals Sales by Countries
6.1.2 North America Oxytocic Pharmaceuticals Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Oxytocic Pharmaceuticals by Product
6.3 North America Oxytocic Pharmaceuticals by End User

7 Europe
7.1 Europe Oxytocic Pharmaceuticals by Countries
7.1.1 Europe Oxytocic Pharmaceuticals Sales by Countries
7.1.2 Europe Oxytocic Pharmaceuticals Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oxytocic Pharmaceuticals by Product
7.3 Europe Oxytocic Pharmaceuticals by End User

8 Asia Pacific
8.1 Asia Pacific Oxytocic Pharmaceuticals by Countries
8.1.1 Asia Pacific Oxytocic Pharmaceuticals Sales by Countries
8.1.2 Asia Pacific Oxytocic Pharmaceuticals Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Oxytocic Pharmaceuticals by Product
8.3 Asia Pacific Oxytocic Pharmaceuticals by End User

9 Central & South America
9.1 Central & South America Oxytocic Pharmaceuticals by Countries
9.1.1 Central & South America Oxytocic Pharmaceuticals Sales by Countries
9.1.2 Central & South America Oxytocic Pharmaceuticals Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Oxytocic Pharmaceuticals by Product
9.3 Central & South America Oxytocic Pharmaceuticals by End User

10 Middle East and Africa
10.1 Middle East and Africa Oxytocic Pharmaceuticals by Countries
10.1.1 Middle East and Africa Oxytocic Pharmaceuticals Sales by Countries
10.1.2 Middle East and Africa Oxytocic Pharmaceuticals Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Oxytocic Pharmaceuticals by Product
10.3 Middle East and Africa Oxytocic Pharmaceuticals by End User

11 Company Profiles
11.1 Fresenius Kaci
11.1.1 Fresenius Kaci Company Details
11.1.2 Company Business Overview
11.1.3 Fresenius Kaci Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Fresenius Kaci Oxytocic Pharmaceuticals Products Offered
11.1.5 Fresenius Kaci Recent Development
11.2 Biofutura
11.2.1 Biofutura Company Details
11.2.2 Company Business Overview
11.2.3 Biofutura Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Biofutura Oxytocic Pharmaceuticals Products Offered
11.2.5 Biofutura Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Company Business Overview
11.3.3 Baxter Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Baxter Oxytocic Pharmaceuticals Products Offered
11.3.5 Baxter Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Oxytocic Pharmaceuticals Products Offered
11.4.5 Pfizer Recent Development
11.5 Ferring
11.5.1 Ferring Company Details
11.5.2 Company Business Overview
11.5.3 Ferring Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Ferring Oxytocic Pharmaceuticals Products Offered
11.5.5 Ferring Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis Oxytocic Pharmaceuticals Products Offered
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Company Business Overview
11.7.3 Teva Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Teva Oxytocic Pharmaceuticals Products Offered
11.7.5 Teva Recent Development

12 Future Forecast
12.1 Oxytocic Pharmaceuticals Market Forecast by Regions
12.1.1 Global Oxytocic Pharmaceuticals Sales Forecast by Regions 2019-2025
12.1.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Regions 2019-2025
12.2 Oxytocic Pharmaceuticals Market Forecast by Product
12.2.1 Global Oxytocic Pharmaceuticals Sales Forecast by Product 2019-2025
12.2.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Product 2019-2025
12.3 Oxytocic Pharmaceuticals Market Forecast by End User
12.4 North America Oxytocic Pharmaceuticals Forecast
12.5 Europe Oxytocic Pharmaceuticals Forecast
12.6 Asia Pacific Oxytocic Pharmaceuticals Forecast
12.7 Central & South America Oxytocic Pharmaceuticals Forecast
12.8 Middle East and Africa Oxytocic Pharmaceuticals Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oxytocic Pharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

1.1 Methodology/Research Approach

Our research methodology implements a mix of primary as well as secondary research. Our projects are initiated with secondary research, where we refer to a variety of sources including trade databases; government published documents, investor presentations, company annual reports, white papers, and paid databases.

1.1.1 Research Programs/Design

1.1.2 Market Size Estimation

Post the initial data mining stage, we gather our findings and analyse them, filtering out relevant insights. These are evaluated across teams and by our in-house SMEs. Along with data mining, we also initiate the primary research phase in which we interact with companies operating within the market space.

To evaluate the wholeness of the market, we interact (via email or telephone) with players who are responsible in adding value to the final product. Additionally, we interact with related industries to understand the external factors that can drive/hamper a market. We also make it a point to evaluate various economic parameters, which typically, have an impact on the purchasing choices of individuals as well as companies.

Post these stages, data are cross-verified with the companies that operate in a market space. It is important for us to study these companies in detail, to understand their existing performance and future strategies which will define the market in the coming years.

All this data is collected and evaluated by our analysts. Post the preparation of the report and data analysis, the findings are presented to our in-house experts who then eliminate discrepancies (if any).

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares splits, and breakdowns have been determined using secondary sources and verified through primary sources.

1.2 Data Source

1.2.1 Secondary Sources

In the secondary research process, various secondary sources, such as D&B Hoovers, Bloomberg BusinessWeek, and Factiva, have been referred to, for identifying and collecting information for this study. Secondary sources included annual reports, press releases, and investor presentations of companies; whitepapers, certified publications, and articles by recognized authors; gold standard and silver standard websites; regulatory bodies; trade directories; and databases.

List of secondary sources include but are not limited to:

  • Academic Journals
  • Census.gov
  • Bloomberg
  • Company Annual Report
  • Hoovers

1.2.1.1 Preliminary data mining

Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For comprehensive understanding of the market, it is essential to understand the complete value chain and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.

Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.

1.2.2 Primary Sources

This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, on face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation, but also provide critical insights into the market, current business scenario and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:

  • Market leading companies
  • Raw material suppliers
  • Product distributors
  • Buyers

The key objectives of primary research are as follows:

  • To validate our data in terms of accuracy and acceptability
  • To gain an insight in to the current market and future expectations

1.2.3 Statistical model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise.

Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of technology landscape, regulatory frameworks, economic outlook and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:

  • Market drivers and restrains, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2026

We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.

1.2.4 Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above, the market was split into several segments and sub segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying several factors and trends from both the demand and supply sides.

1.2.5 Report Objectives

  • To define, describe, and forecast the market by segmentations, and region
  • To provide detailed information about the major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the market
  • To analyze the sub-segments with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide the competitive landscape of the market
  • To forecast the revenues of the market segments with respect to the major regions, such as North America, Europe, Asia Pacific (APAC), and RoW
  • To profile the key players and comprehensively analyze their recent developments and positioning in the market
  • To analyze competitive developments, such as mergers and acquisitions, new product developments, and Research and Development (R&D) activities, in the market
Purchase
Specs
Release date:September 26, 2019
Last updated:January 1, 1970
File Type:PDF
Category:Machinery & Equipment
Number Of Pages:100-150
Specs
Release date:September 26, 2019
Last updated:January 1, 1970
File Type:PDF
Category:Machinery & Equipment
Number Of Pages:100-150

Purchase Report

Purchase

Download Category:

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why SMR?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements